113 related articles for article (PubMed ID: 37044020)
1. Downregulated miR-495-3p in colorectal cancer targets TGFβR1, TGFβR2, SMAD4 and BUB1 genes and induces cell cycle arrest.
Kabiri F; Medlej A; Saleh AJ; Aghdami N; Khani M; Soltani BM
Cancer Treat Res Commun; 2023; 35():100702. PubMed ID: 37044020
[TBL] [Abstract][Full Text] [Related]
2. Hsa-miR-5195-3P induces downregulation of TGFβR1, TGFβR2, SMAD3 and SMAD4 supporting its tumor suppressive activity in HCT116 cells.
Jahangiri Moez M; Bjeije H; Soltani BM
Int J Biochem Cell Biol; 2019 Apr; 109():1-7. PubMed ID: 30659889
[TBL] [Abstract][Full Text] [Related]
3. Hsa-miR-5582-3P regulatory effect on TGFβ signaling through targeting of TGFβ-R1, TGFβ-R2, SMAD3, and SMAD4 transcripts.
Abedini Bakhshmand E; Mohammad Soltani B; Fasihi A; Mowla SJ
J Cell Biochem; 2018 Dec; 119(12):9921-9930. PubMed ID: 30129155
[TBL] [Abstract][Full Text] [Related]
4. Regulatory effect of hsa-miR-5590-3P on TGFβ signaling through targeting of TGFβ-R1, TGFβ-R2, SMAD3 and SMAD4 transcripts.
Abedini Bakhshmand E; Soltani BM
Biol Chem; 2019 Apr; 400(5):677-685. PubMed ID: 30391930
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-490-3p inhibits colorectal cancer metastasis by targeting TGFβR1.
Xu X; Chen R; Li Z; Huang N; Wu X; Li S; Li Y; Wu S
BMC Cancer; 2015 Dec; 15():1023. PubMed ID: 26714817
[TBL] [Abstract][Full Text] [Related]
6. Hsa-miR-587 Regulates TGFβ/SMAD Signaling and Promotes Cell Cycle Progression.
Jahangirimoez M; Medlej A; Tavallaie M; Mohammad Soltani B
Cell J; 2020 Jul; 22(2):158-164. PubMed ID: 31721529
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of microRNA-21-3p suppresses proliferation as well as invasion and induces apoptosis by targeting RNA-binding protein with multiple splicing through Smad4/extra cellular signal-regulated protein kinase signalling pathway in human colorectal cancer HCT116 cells.
Hou N; Guo Z; Zhao G; Jia G; Luo B; Shen X; Bai Y
Clin Exp Pharmacol Physiol; 2018 Jul; 45(7):729-741. PubMed ID: 29542167
[TBL] [Abstract][Full Text] [Related]
8. Cell specific tumor suppressor effect of Hsa-miR-1226-3p through downregulation of HER2, PIK3R2, and AKT1 genes.
Mohamadzade Z; M Soltani B; Ghaemi Z; Hoseinpour P
Int J Biochem Cell Biol; 2021 May; 134():105965. PubMed ID: 33675995
[TBL] [Abstract][Full Text] [Related]
9. LOC646329 long non-coding RNA sponges miR-29b-1 and regulates TGFβ signaling in colorectal cancer.
Javanmard AR; Dokanehiifard S; Bohlooli M; Soltani BM
J Cancer Res Clin Oncol; 2020 May; 146(5):1205-1215. PubMed ID: 32034483
[TBL] [Abstract][Full Text] [Related]
10. Hsa-miR-186-5p regulates TGFβ signaling pathway through expression suppression of SMAD6 and SMAD7 genes in colorectal cancer.
Bayat Z; Ghaemi Z; Behmanesh M; Soltani BM
Biol Chem; 2021 Mar; 402(4):469-480. PubMed ID: 33938174
[TBL] [Abstract][Full Text] [Related]
11. miR-224 Controls Human Colorectal Cancer Cell Line HCT116 Proliferation by Targeting Smad4.
Zhou J; Hu M; Wang F; Song M; Huang Q; Ge B
Int J Med Sci; 2017; 14(10):937-942. PubMed ID: 28924364
[No Abstract] [Full Text] [Related]
12. YWHAE long non-coding RNA competes with miR-323a-3p and miR-532-5p through activating K-Ras/Erk1/2 and PI3K/Akt signaling pathways in HCT116 cells.
Bjeije H; Soltani BM; Behmanesh M; Zali MR
Hum Mol Genet; 2019 Oct; 28(19):3219-3231. PubMed ID: 31238337
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Inhibition of miR-4260 Suppresses Colorectal Cancer via Targeting MCC and SMAD4.
Xiao J; Lv D; Zhou J; Bei Y; Chen T; Hu M; Zhou Q; Fu S; Huang Q
Theranostics; 2017; 7(7):1901-1913. PubMed ID: 28638476
[TBL] [Abstract][Full Text] [Related]
14. miR-34a mediates oxaliplatin resistance of colorectal cancer cells by inhibiting macroautophagy
Sun C; Wang FJ; Zhang HG; Xu XZ; Jia RC; Yao L; Qiao PF
World J Gastroenterol; 2017 Mar; 23(10):1816-1827. PubMed ID: 28348487
[TBL] [Abstract][Full Text] [Related]
15. Introduction of hsa-miR-512-3p as a new regulator of HER2 signaling pathway in breast cancer.
Mohamadzade Z; Mahjoubi F; Soltani BM
Breast Cancer Res Treat; 2021 Jan; 185(1):95-106. PubMed ID: 32974790
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of miR-518a-3p activates the NIK-dependent NF-κB pathway in colorectal cancer.
Qu LL; He L; Zhao X; Xu W
Int J Mol Med; 2015 May; 35(5):1266-72. PubMed ID: 25812680
[TBL] [Abstract][Full Text] [Related]
17. MiR-103a-3p Contributes to the Progression of Colorectal Cancer by Regulating GREM2 Expression.
Zhang Z; Zhu X
Yonsei Med J; 2022 Jun; 63(6):520-529. PubMed ID: 35619575
[TBL] [Abstract][Full Text] [Related]
18. miR-130b-3p is high-expressed in polycystic ovarian syndrome and promotes granulosa cell proliferation by targeting SMAD4.
Bao D; Li M; Zhou D; Zhuang C; Ge Z; Wei Q; Zhang L
J Steroid Biochem Mol Biol; 2021 May; 209():105844. PubMed ID: 33582305
[TBL] [Abstract][Full Text] [Related]
19. A Novel Role for MiR-520a-3p in Regulating EGFR Expression in Colorectal Cancer.
Zhang R; Liu R; Liu C; Niu Y; Zhang J; Guo B; Zhang CY; Li J; Yang J; Chen X
Cell Physiol Biochem; 2017; 42(4):1559-1574. PubMed ID: 28738328
[TBL] [Abstract][Full Text] [Related]
20. NLK, a novel target of miR-199a-3p, functions as a tumor suppressor in colorectal cancer.
Han Y; Kuang Y; Xue X; Guo X; Li P; Wang X; Guo X; Yuan B; Zhi Q; Zhao H
Biomed Pharmacother; 2014 Jun; 68(5):497-505. PubMed ID: 24972723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
